EDGAR Filing Documents for 0001193125-13-208007

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-13-208007

Filing Date

2013-05-09

Accepted

2013-05-08 18:14:21

Documents

Period of Report

2013-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	d500632d10q.htm	10-Q	593665
2	EX-31.1	d500632dex311.htm	EX-31.1	7707
3	EX-31.2	d500632dex312.htm	EX-31.2	7726
4	EX-32.1	d500632dex321.htm	EX-32.1	4301
11	GRAPHIC	g500632txpg021.jpg	GRAPHIC	30296
	Complete submission text file	0001193125-13-208007.txt		4183958

Data Files

Seq	Description	Document	Type	Size
5	XBRL INSTANCE DOCUMENT	avnr-20130331.xml	EX-101.INS	479605
6	XBRL TAXONOMY EXTENSION SCHEMA	avnr-20130331.xsd	EX-101.SCH	49020
7	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	avnr-20130331_cal.xml	EX-101.CAL	48519
8	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	avnr-20130331_def.xml	EX-101.DEF	123916
9	XBRL TAXONOMY EXTENSION LABEL LINKBASE	avnr-20130331_lab.xml	EX-101.LAB	378585
10	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	avnr-20130331_pre.xml	EX-101.PRE	255573

Mailing Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656

Business Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656 949-389-6700

AVANIR PHARMACEUTICALS, INC. (Filer) CIK: 0000858803 (see all company filings)